These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28213761)

  • 1. Psychomotor effect differences between l-methamphetamine and d-methamphetamine are independent of murine plasma and brain pharmacokinetics profiles.
    Nishimura T; Takahata K; Kosugi Y; Tanabe T; Muraoka S
    J Neural Transm (Vienna); 2017 May; 124(5):519-523. PubMed ID: 28213761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats.
    Okuda T; Ito Y; Nakagawa N; Hishinuma T; Tsukamoto H; Iwabuchi K; Watanabe T; Kitaichi K; Goto J; Yanai K
    Eur J Pharmacol; 2004 Nov; 505(1-3):135-44. PubMed ID: 15556146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
    Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
    Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
    J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice lacking d-amino acid oxidase activity exhibit marked reduction of methamphetamine-induced stereotypy.
    Hashimoto A; Konno R; Yano H; Yoshikawa M; Tamaki R; Matsumoto H; Kobayashi H
    Eur J Pharmacol; 2008 May; 586(1-3):221-5. PubMed ID: 18448092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacology of the methamphetamine stereoisomers.
    Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
    Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantity of stereotyped behavior of ddY mice induced by low-dose methamphetamine.
    Masuda Y; Matsuda Y; Kondoh M; Shimizu T; Hishikawa Y
    Exp Anim; 1996 Jul; 45(3):279-81. PubMed ID: 8840148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats.
    Byrnes-Blake KA; Laurenzana EM; Carroll FI; Abraham P; Gentry WB; Landes RD; Owens SM
    Eur J Pharmacol; 2003 Feb; 461(2-3):119-28. PubMed ID: 12586207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as "bath salts".
    López-Arnau R; Martínez-Clemente J; Carbó Ml; Pubill D; Escubedo E; Camarasa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():64-72. PubMed ID: 23603357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetic properties of methamphetamine in rats with previous repeated exposure to methamphetamine: the differences between Long-Evans and Wistar rats.
    Fujimoto Y; Kitaichi K; Nakayama H; Ito Y; Takagi K; Takagi K; Hasegawa T
    Exp Anim; 2007 Apr; 56(2):119-29. PubMed ID: 17460357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice.
    Phillips TJ; Dickinson S; Burkhart-Kasch S
    Behav Neurosci; 1994 Aug; 108(4):789-803. PubMed ID: 7986372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
    Chen PC; Lao CL; Chen JC
    J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor behavioural function for histamine-dopamine interaction in brain.
    Onodera K; Itoh C; Sato M; Watanabe T
    Inflamm Res; 1998; 47 Suppl 1():S30-1. PubMed ID: 9561402
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.
    Hall DA; Stanis JJ; Marquez Avila H; Gulley JM
    Psychopharmacology (Berl); 2008 Jan; 195(4):469-78. PubMed ID: 17874316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of N-cyanomethylmethamphetamine, a product derived from smoking methamphetamine with tobacco, in mice and rats.
    Sekine H; Nagao S; Kuribara H; Nakahara Y
    Pharmacol Biochem Behav; 1997; 57(1-2):167-72. PubMed ID: 9164568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat.
    Wisor JP; Dement WC; Aimone L; Williams M; Bozyczko-Coyne D
    Pharmacol Biochem Behav; 2006 Nov; 85(3):492-9. PubMed ID: 17134745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.
    Schepers RJ; Oyler JM; Joseph RE; Cone EJ; Moolchan ET; Huestis MA
    Clin Chem; 2003 Jan; 49(1):121-32. PubMed ID: 12507968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.